Tuesday, October 5, 2010

IVF Pioneer Robert Edwards of Britain Wins Nobel Prize in Medicine 2010

STOCKHOLM (Oct. 4) -- Robert Edwards of Britain won the 2010 Nobel Prize in medicine on Monday for developing in-vitro fertilization, a controversial breakthrough that ignited sharp criticism from religious leaders but helped millions of infertile couples in the last three decades have children.

Edwards, an 85-year-old professor emeritus at the University of Cambridge, started working on IVF as early as the 1950s. He developed the technique - in which egg cells are removed from a woman, fertilized outside her body and then implanted into the womb - together with British gynecologist surgeon Patrick Steptoe, who died in 1988.


On July 25, 1978, Louise Brown in Britain became the first baby born through the groundbreaking procedure, marking a revolution in fertility treatment.

"(Edwards') achievements have made it possible to treat infertility, a medical condition afflicting a large proportion of humanity, including more than 10 percent of all couples worldwide," the medicine prize committee in Stockholm said in its citation.

"Approximately 4 million individuals have been born thanks to IVF," the citation said. "Today, Robert Edwards' vision is a reality and brings joy to infertile people all over the world."

Steptoe and Edwards developed IVF from the early beginning experiments into a practical course of medicine and founded the first IVF clinic at Bourn Hall in Cambridge in 1980.

Today, the probability that an infertile couple will take home a baby after a cycle of IVF is 1 in 5, about the same odds that healthy couples have of conceiving naturally.

Prize committee secretary Goran Hansson said Edwards was not in good health Monday when the committee tried to reach him. Bourn Hall said Edwards was too ill to give interviews.

"I spoke to his wife and she was delighted and she was sure he would be delighted too," Hansson told reporters in Stockholm after announcing the 10 million kronor ($1.5 million) award.

"Louise's birth signified so much," Edwards said at Brown's 25th birthday celebration in 2003. "We had to fight a lot of opposition but we had concepts that we thought would work and they worked."

Brown, now 32, reportedly is a postal worker in the English coastal city of Bristol. In 2007 she gave birth to her first child - a boy named Cameron. She said the child was conceived naturally.

"Its fantastic news, me and mum are so glad that one of the pioneers of IVF has been given the recognition he deserves. We hold Bob in great affection and are delighted to send our personal congratulations," Brown said in a statement released by Bourn Hall.

The work by Edwards and Steptoe stirred a "lively ethical debate," the Nobel citation said, with the Vatican, other religious leaders and some scientists demanding the project be stopped. When the British Medical Research Council declined funding for Steptoe and Edwards, a private donation allowed them to continue their research.

The Vatican is opposed to IVF because it involves separating conception from the "conjugal act" - sexual intercourse between a husband and wife - and often results in the destruction of human embryos that are taken from a woman but not used.

There was no immediate comment from the Vatican's top bioethics officials Monday to word of the Nobel.

In a statement, Bourn Hall said one of Edwards' proudest moments was discovering that 1,000 IVF babies had been born at the clinic since Brown, and relaying that information to a seriously ill Steptoe shortly before his death in 1988.

"I'll never forget the look of joy in his eyes," Edwards said.

William Ledger, head of reproductive and developmental medicine at Sheffield University, called the award "an appropriate recognition" for Edwards.

"The only sadness is that Patrick Steptoe has not lived to see this day because it was always a joint team effort between the two of them," Ledger said.

Steptoe was not honored with a prize because Nobel rules were amended in 1974 to prohibit posthumous prizes.

Other experts criticized Britain for not honoring Edwards earlier with a knighthood.

"It's a shame Britain hasn't recognized him in a more explicit fashion," said Francoise Shenfield, infertility expert with the European Society of Human Reproduction and lecturer in medical ethics at University College London.

In an interview with The Times of London in 2003, Edwards said he was "not terribly bothered" about not getting a knighthood.

"I'm a very left-wing socialist and I won't shed a tear. But if you can organize a Nobel, please go ahead," he joked.

Aleksander Giwercman, head of reproduction research at the University of Lund in Sweden, said Edwards' achievements also provided tools for other areas of research, including cancer and stem cells.

"Many of the illnesses that develop when we are adults have their origin early on in life, during conception," Giwercman said.

The controversy over in-vitro technology has not dimmed despite its popularity. In the last few years, the increasing use of IVF has also raised discussions about what age it's appropriate to become a mother. In 2006, a 67-year-old Spanish woman became a mother after she used IVF technology to conceive twins, only to die herself two years later.

The medicine award was the first of the 2010 Nobel Prizes to be announced. It will be followed by physics on Tuesday, chemistry on Wednesday, literature on Thursday, the Nobel Peace Prize on Friday and economics on Monday Oct. 11.




Sunday, March 28, 2010

More about LIPIDS

if you want to know more about lipids;please go through this link
http://www.lipidmaps.org/

Sunday, February 7, 2010

An Overview of Clinical Laboratory Quality Control

Definitions


Quality Control - QC refers to the measures that must be included during each assay run to verify that the test is working properly.

Quality Assurance - QA is defined as the overall program that ensures that the final results reported by the laboratory are correct.

“The aim of quality control is simply to ensure that the results generated by the test are correct. However, quality assurance is concerned with much more: that the right test is carried out on the right specimen, and that the right result and right interpretation is delivered to the right person at the right time”

Quality Assessment - quality assessment (also known as proficiency testing) is a means to determine the quality of the results generated by the laboratory. Quality assessment is a challenge to the effectiveness of the QA and QC programs. Quality Assessment may be external or internal.

Variables that affect the quality of results

The educational background and training of the laboratory personnel


 The condition of the specimens


 The controls used in the test runs


 Reagents


 Equipment


 The interpretation of the results


 The transcription of results


 The reporting of results

Errors in measurement

 True value - this is an ideal concept which cannot be achieved.

 Accepted true value - the value approximating the true value, the difference between the two values is negligible.

 Error - the discrepancy between the result of a measurement and the true (or accepted true value).

Sources of error

 Input data required - such as standards used, calibration values, and values of physical constants.

 Instruments used - accuracy, repeatability.

 Observer fallibility - reading errors, blunders, equipment selection, analysis and computation errors.

 Environment - any external influences affecting the measurement.

 Theory assumed - validity of mathematical methods and approximations.

Types of Errors in a Clinical Laboratory

 Crude Error [all the pre-analytical errors]

 Random Errors [all the sample & Technical errors]

 Systematic Errors

Random Error

 An error which varies in an unpredictable manner, in magnitude and sign, when a large number of measurements of the same quantity are made under effectively identical

conditions.

 Random errors create a characteristic spread of results for any test method and cannot be accounted for by applying corrections. Random errors are difficult to eliminate but repetition reduces the influences of random errors.

 Examples of random errors include errors in pipetting and changes in incubation period. Random errors can be minimized by training, supervision and adherence to standard operating procedures.

 Random Errors – these errors affect the reproducibility or precision of a test system.

 Usually 13S or R4S rules can be due to variations in line voltage, pipettes, dispensers,contamination, volume dispensed, bubbles in lines of reagents, etc.

Systematic Error

 An error which, in the course of a number of measurements of the same value of a given quantity, remains constant when measurements are made under the same conditions,or varies according to a definite law when conditions change.

 Systematic errors create a characteristic bias in the test results and can be accounted for by applying a correction.

 Systematic errors may be induced by factors such as variations in incubation temperature, blockage of plate washer, change in the reagent batch or modifications in testing method.

Systematic Errors – (bias, shifts and trends) – these errors affect the accuracy of the test system.

 Usually 22S, 41S, or 10x rules can be due to calibration lot changes,temperature changes in incubator unit, light source deterioration, electronics, reagent lot changes,

etc.

Shewhart Control Charts

A Shewhart Control Chart depend on the use of IQC specimens and is developed in the following manner:-

 Put up the IQC specimen for at least 20 or more assay runs and record down the O.D. with the corresponding dates.

 Calculate the mean and standard deviations (s.d.)

 Make a plot with the assay run on the x-axis, and O.D.on the y axis.

 Draw the following lines across the y-axis: mean, -3, -2, -2, 1, 2 and 3 s.d.

 Plot the O.D./cut-off obtained for the IQC specimen for subsequent assay runs

 Major events such as changes in the batch no. of the kit and instruments used should be recorded on the chart.

Westgard rules

 The formulation of Westgard rules were based on statistical methods. Westgard rules are commonly used to analyse data in Shewhart control charts.

 Westgard rules are used to define specific performance limits for a particular assay and can be use to detect both random and systematic errors.

 There are six commonly used Westgard rules of which three are warning rules and the other three mandatory rules.

 The violation of warning rules should trigger a review of test procedures, reagent performance and equipment calibration.

 The violation of mandatory rules should result in the rejection of the results obtained with patients’ serum samples in that assay.

Follow-up action in the event of a violation

There are three options as to the action to be taken in the event of a violation of a Westgard rule:

 Accept the test run in its entirety - this usually applies when only a warning rule is violated.

 Reject the whole test run - this applies only when a mandatory rule is violated.

 Enlarge the greyzone and thus re-test range for that particular assay run - this option can be considered in the event of a violation of either a warning or mandatory rule.

Typical Rule Combinations

 For controls run in multiples of 2 (typically chemistry)

13S / 22S / R4S / 41S / 10X

 For controls run in multiples of 3 (typically hematology, coagulation, blood gases)

13S / 2of 32S / R4S / 31S / 12X

The Westgard Rules

 The main rues a Clinical Laboratory Follows;

 12S

 13S

 22S

 R4S

 41S

 10x

12S–refers to the historical rule of plus/minus 2s from the mean-with multi-rules: a warning rule to trigger careful inspection of control data

13S-refers to plus/minus 3s a run is rejected when a single control exceeds the mean ± 3s

22S – reject the run when 2 consecutive controls exceed the mean ± 2s

R4S – when 1 control in a group exceeds the mean ± 2s and another control exceeds the mean in the other direction by 2s then reject run

41S – when 4 consecutive control measurements are on one side of the mean either ± 1s Warning rule or a rejection rule depending on the accuracy of your instrument.

10x – 10 consecutive control measurements fall on one side of the mean

a) If within 1 s, warning

b) If between 1 and 2 s, reject

c) 2of 32S – reject the run when 2 of 3 controls exceed the mean ± 2s

• 9x – reject when 9 consecutive control measurements fall on one side of the mean

• 7T – reject when seven control measurements trend in the same direction, either higher or lower

Warning rules

 Warning 12SD : It is violated if the IQC value exceeds the mean by +/-2SD. It is an event likely to occur normally in less than 5% of cases.

 Warning 22SD : It detects systematic errors and is violated when two consecutive IQC values exceed the mean on the same side of the mean by +/-2SD.

 Warning 41SD : It is violated if four consecutive IQC values exceed the same limit (mean +/-1SD) and this may indicate the need to perform instrument maintenance or reagent calibration.

Mandatory rules

 Mandatory 13SD : It is violated when the IQC value exceeds the mean by +/-3SD. The assay run is regarded as out of control.

 Mandatory R4SD : It is only applied when the IQC is tested in duplicate. This rule is violated when the difference in SD between the duplicates exceeds 4SD.

 Mandatory 10x : This rule is violated when the last 10 consecutive IQC values are on the same side of the mean or target value.

Accuracy –vs- Precision

 Accuracy – how close you are to the correct value

 Precision – how close together your results are to each other

Lab should Define a QC Protocol

 Each lab needs to define its’ QC protocol based on the number of controls used, the accuracy of the instrumentation, the total allowable error,etc.

QC Protocol - example

1. Statistical QC Procedure

a) Use a 12S as a warning rule and the 13S / 22S / R4S / 41S / 10X as rejection rules with 2 control measurements

2. Analyze control materials

a) Analyze 1 sample of each level of control.

3. Interpretation of warning rules

a) If both control results are within 2s, report the results.

If one control exceeds a 2s limit,follow flow chart and if any rule is violated,reject run.

4.Within run inspection

a) Inspect control results by applying rules: 13S in each run and 22S and R4S across levels.

5. Inspect controls across runs

a) Apply the 22S rule with each level across the last two runs.

b) Apply the 41S rule within each control level across the last 4 runs and across the last 2 runs of both levels.

6. If none of the rules are violated, accept the run.

Problem Solving

 If a run is out of control, investigate the process and correct the problem

Do not automatically repeat the control!

What do you need to do to investigate the process?

 Determine the type of error based on your rule violation (random or systematic)

 Relate the type of error to the potential cause

 Inspect the testing process and consider common factors on multi-test systems

 Relate causes to recent changes

 Verify the solution and document the corrective action

The records we need

 Instrument Information & Validation

 Reportable range (linearity)

 Precision and Accuracy studies

 Analytical sensitivity / specificity

 Reference range

 Proficiency testing results

 Reagent logs

 Problem logs

QC Documents / Logs

Preventative maintenance

 Scheduled and unscheduled

 Reason for maintenance

 Frequency and length of downtime

 Signs of instrument deterioration

 Lot numbers and expiry of calibrators, dates of calibration, reason for calibration/verification, and by whom

Instrument function and temperature checks

Previous Control runs

All of these documents can be helpful when investigating errors!

Why use Westgard Rules?

 We use Westgard Multi-rules to help us reduce costs while maintaining a high level of certainty that our analytical process is functioning properly.

 In other words to diminish the false rejection rate without compromising quality.



Courtesy: Westgard website

Friday, February 5, 2010

Food intolerance

Food intolerance
It is a delayed, negative reaction to a food, beverage or food additive. Food intolerance is an adverse reaction to some sort of food or ingredient that occurs every time the food is eaten, but particularly if larger quantities are consumed. This isn't the same as a food allergy or food poisoning.
Food intolerance occurs when the body is unable to deal with a certain type of foodstuff. This is usually because the body doesn't produce enough of the particular chemical or enzyme that's needed for digestion of that food.
Example: Intolerance of cow's milk, which contains a type of sugar called lactose. This is caused by shortage of the enzyme lactase, which is normally made by cells lining the small intestine. Without this enzyme they can't break down milk sugar into simpler forms that can be absorbed into the bloodstream.
The lack of a specific enzyme in the body may lead to the build up of toxic byproducts and histamine, which then mimic the symptoms of an allergy. This is called a 'pseudo-allergic' reaction.
Food intolerances are rarely harmful but may cause unpleasant symptoms, including nausea, bloating, abdominal pain and diarrhoea, which can begin hours or days after eating or drinking the food in question.
The severity of symptoms varies depending on the amount of enzyme the person makes and how much of the food has been consumed. In alcohol intolerance, there may be intense flushing of the skin, nausea, palpitations, headache and feeling faint.
Diagnosis can include an elimination diet and challenge testing. The antigen leukocyte cellular antibody test (ALCAT) has been commercially promoted as an alternative, but has not been reliably shown to be of clinical value. Clinical investigation is generally undertaken only for more serious cases, as for minor complaints which do not significantly limit the person's lifestyle the cure may be more inconvenient than the problem. Treatment can involve avoidance, and re-establishing a level of tolerance.
Some common Intolerance’s
Sucrose intolerance, also called congenital sucrase-isomaltase deficiency (CSID)or Sucrase-isomaltase deficiency,is the condition in which sucrase, an enzyme needed for proper metabolization of sucrose, is not produced in the small intestine.It is more common among the Inupiat.
Fructose intolerance: Fructose intolerance may refer to:
Ø  Fructose malabsorption - a digestive disorder of the small intestine in which the fructose carrier in enterocytes is deficient.
Ø  Hereditary fructose intolerance - a hereditary condition caused by a deficiency of liver enzymes that metabolise fructose.
Fructose malabsorption, formerly named "dietary fructose intolerance", is a digestive disorder of the small intestine in which the fructose carrier in enterocytes is deficient. This problem results in the concentration of fructose in the entire intestine to be increased. Hereditary fructose intolerance (HFI) or fructose poisoning is a hereditary condition caused by a deficiency of liver enzymes that metabolise fructose. It is also known as hereditary fructosemia.
Citric acid intolerance : Citric acid intolerance is a little-known type of food intolerance in which sufferers report various symptoms in response to foods or other products containing citric acid that they attribute neither to its properties as an acid nor to an Aspergillus niger hypersensitivity.
Lactose intolerance is the inability to metabolize lactose, because of a lack of the required enzyme lactase in the digestive system.
There are three major types of lactose intolerance:
Ø  Primary lactose intolerance. Environmentally induced when weaning a child in non–dairy consuming societies.This is found in many Asian and African cultures, where industrialized and commercial dairy products are uncommon.
Ø  Secondary lactose intolerance. Environmentally induced, resulting from certain gastrointestinal diseases, including exposure to intestinal parasites such as Giardia lamblia.In such cases the production of lactase may be permanently disrupted.A very common cause of temporary lactose intolerance is gastroenteritis, particularly when the gastroenteritis is caused by rotavirus. Another form of temporary lactose intolerance is lactose overload in infants.
Ø  Congenital lactase deficiency. A genetic disorder which prevents enzymatic production of lactase. Present at birth, and diagnosed in early infancy.
Drug intolerance or drug sensitivity is a lower threshold to the normal pharmacologic action of a drug. It is not to be confused with drug allergy. Drug intolerance is uncommon and idiopathic, thus extremely difficult to predict except in persons with a prior history or a family history of intolerance to that specific drug. Some drug intolerances are known to result from genetic variants of drug metabolism.

Friday, January 29, 2010

Nutritional and Metabolic Diseases

http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gnd∂=A86

Biochemistry of Metabolism

http://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb1/MB1index.html

The National Center for Biotechnology Information

http://www.ncbi.nlm.nih.gov/guide/

The Medical Biochemistry

http://themedicalbiochemistrypage.org/

Metabolic Pathways of Biochemistry

http://www.extremebodyworkout.com/information/exploring-metabolic-pathways.php

All about enzyme information

http://www.brenda-enzymes.info/

HIV & HBV structures




HEPATITIS B Virus Structure

List of Biomolecules

List of Biomolecules
A
B
C
D
E
F
G
H
I
J
K
L
For substances with an l- or L- prefix such as L-alanine or DL-alanine, please see the parent page (in this case alanine).
M
N
O
P
Q
R
S
T
U
V
 W
 X
 Z